Abbratech Inc.

Branford, CT Part of Abbratech Holdings LLC

UEI
G7S7M6L41EX5
CAGE
8VPC6
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
  • Self Certified Small Disadvantaged Business
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Website
abbratech.com
Founded
2020
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Abbratech Inc. is a corporate entity registered in SAM.gov, located in Branford, Connecticut, that specializes in advanced biotechnology research and development, with a particular focus on antibody engineering and innovative molecular biology technologies. As a self-certified small disadvantaged business, the company has developed proprietary platforms for antibody generation, validation, and characterization, with a core technological approach centered around their unique "EpiVolve" phage display technology. The company appears to be primarily engaged in biomedical research, targeting complex challenges in protein analysis, immunotherapy, and diagnostic reagent development.

Through federal grant awards, primarily from the National Institute of General Medical Sciences (NIGMS) and the National Institute of Allergy and Infectious Diseases (NIAID), Abbratech Inc. has pursued multiple research initiatives focused on developing advanced antibody generation platforms. Their grant-funded projects have included developing site-specific antibodies for targeting protein splice variants, creating T-cell receptor mimic antibodies for precision oncology, generating neutralizing antibodies for viral research (including SARS-CoV-2 and Influenza A), and establishing high-throughput methods for antibody validation and production. The company has also engaged in sub-awards with the University of Connecticut Health Center, specifically contributing to anti-treponemal cell surface antibody research by designing peptides, identifying antibodies, performing ELISA and Western analysis, and supporting data analysis for molecular typing and genomics manuscripts. These diverse research efforts demonstrate Abbratech's sophisticated capabilities in molecular biology, immunology, and biotechnology research and development.

Quick answers

Is Abbratech Inc. registered in SAM.gov?

Yes. Abbratech Inc.'s SAM.gov registration is active through August 17, 2027.

What is Abbratech Inc.'s CAGE code?

Abbratech Inc.'s CAGE code is 8VPC6, and its Unique Entity ID (UEI) is G7S7M6L41EX5.

What is Abbratech Inc.'s most recent federal award?

Abbratech Inc.'s most recent federal grant award is Directed discovery and validation of anti-splice-junction site ABS (R44GM156476), from National Institute of General Medical Sciences (NIH), on September 20, 2024.

On GovTribe

See Abbratech Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe